Predicting achievement of the treatment targets at 6 months from 3-month response levels in rheumatoid arthritis: data from real-life follow-up in the NOR-DMARD study

OBJECTIVE: When initiating a new therapy in patients with rheumatoid arthritis (RA), current treatment recommendations suggest escalating therapy in case of poor clinical improvement by 3 months or if the treatment target has not been reached by 6 months. We investigated which disease activity impro...

Descripción completa

Detalles Bibliográficos
Autores principales: Norvang, Vibeke, Sexton, Joseph, Kristianslund, Eirik K, Olsen, Inge C, Uhlig, Till, Bakland, Gunnstein, Krøll, Frode, Rødevand, Erik, Wierød, Ada, Kvien, Tore K, Smolen, Josef S, Aletaha, Daniel, Haavardsholm, Espen A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6242030/
https://www.ncbi.nlm.nih.gov/pubmed/30488000
http://dx.doi.org/10.1136/rmdopen-2018-000773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6242030/
https://www.ncbi.nlm.nih.gov/pubmed/30488000
http://dx.doi.org/10.1136/rmdopen-2018-000773

Ejemplares similares